Term ends no later than Sep 21, 2029 · Medium confidence
20-year base term ends Sep 21, 2029
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Sep 21, 2009
Sep 21, 2029
May 11, 2010
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 21, 2009, when this application, 12/563,821, was filed | Sep 21, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Sep 21, 2029 | Medium confidence |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 8, 2010 reel/frame not recorded | Krishna, Gopal; Motheram, Rajeshwar; Palepu, Nagesh; Shah, Praful | The Medicines Company | Assignment of Assignor's Interest |
| Jun 8, 2010 reel/frame not recorded | Krishna, Gopal; Motheram, Rajeshwar; Palepu, Nagesh; Shah, Praful | Eagle Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jun 8, 2010 Reel 24492, frame 434 | Palepu, Nagesh; Motheram, Rajeshwar; Shah, Praful; Krishna, Gopal | The Medicines Company; Eagle Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jan 26, 2017 Reel 41095, frame 554 | Eagle Pharmaceuticals, Inc. | JPMorgan Chase Bank, N.A., as Administrative Agent | Security Interest |
| Dec 17, 2018 Reel 47794, frame 61 | The Medicines Company | Sandoz Inc. | Assignment of Assignor's Interest |
| Apr 1, 2025 Reel 70703, frame 524 | JPMorgan Chase Bank, N.A., as Administrative Agent | Eagle Pharmaceuticals, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Sep 21, 2029. We will not guess the cap.